Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions or take the drugs to become eligible for other services,

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and their newer cousin, Mounjaro – are expensive, and mostly only available on private prescription.

The weight-loss drug Ozempic could increase the risk of vision loss, a new study found. Ozempic has been hailed as a gamechanger with the potential to save millions of lives, and billions of pounds. Illnesses caused by obesity cost the NHS more than £11 billion per year,

The drug is usually prescribed to those with diabetes